Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 26,050 KRW
Change Today -1,050.00 / -3.87%
Volume 65.6K
As of 2:25 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

reyon pharmaceutical co ltd (102460) Snapshot

Open
27,000
Previous Close
27,100
Day High
27,100
Day Low
25,750
52 Week High
04/22/15 - 33,000
52 Week Low
05/8/14 - 18,100
Market Cap
336.0B
Average Volume 10 Days
243.4K
EPS TTM
899.00
Shares Outstanding
12.9M
EX-Date
12/29/14
P/E TM
29.0x
Dividend
250.00
Dividend Yield
0.96%
Current Stock Chart for REYON PHARMACEUTICAL CO LTD (102460)

Related News

No related news articles were found.

reyon pharmaceutical co ltd (102460) Related Businessweek News

No Related Businessweek News Found

reyon pharmaceutical co ltd (102460) Details

REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and active pharmaceutical ingredients in South Korea and internationally. The company offers various products, such as injections, eye drops, antibiotics, coagulation drugs, skeletal muscle relaxants, anti-inflammatory enzymes, local anesthics, blood vessel dialectic drugs, anti cancer drugs, cardiac strengthening drugs, and anti-inflammatory pain relievers. It also produces raw materials used for the manufacture of drugs with a production system applying fermentation, purification, and organic synthesis technology. The company was founded in 1955 and is based in Seoul, South Korea.

Founded in 1955

reyon pharmaceutical co ltd (102460) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

reyon pharmaceutical co ltd (102460) Key Developments

REYON Pharmaceutical Co., Ltd., Annual General Meeting, Mar 27, 2015

REYON Pharmaceutical Co., Ltd., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Location: lengthy 23 (Itaewon) Capital Hotel Venus first floor hall. Agenda: To consider the audit report and business report; to consider groups (2014) financial statements and appropriation of retained earnings; to consider some change in Articles of Incorporation; to consider approval of director; and to consider approval of the remuneration.

REYON Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jan 17, 2014

REYON Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jan 17, 2014., at 10:00 Korea Standard Time. Location: 3rd floor, 26 to go 6 clear room. Agenda: To consider the audit report; to consider the some change in constitution; and to consider the appointment of two internal directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
102460:KS 26,050.00 KRW -1,050.00

102460 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 102460.
View Industry Companies
 

Industry Analysis

102460

Industry Average

Valuation 102460 Industry Range
Price/Earnings 30.5x
Price/Sales 3.2x
Price/Book 2.3x
Price/Cash Flow 30.3x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REYON PHARMACEUTICAL CO LTD, please visit www.reyonpharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.